Piedmont Healthcare

Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial (2022) Kario K, Mahfoud F, Kandzari DE, Townsend RR, Weber MA, Schmieder R, Tsioufis K, et al. Journal article A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis (2022) Bowlus CL, Galambos MR, Aspinall RJ, Hirschfield GM, Jones DE, Dörffel Y, Gordon SC, et al. Journal article Reasons for antihypertensive medication nonadherence influence physician preferences for hypertension management (2021) Schmieder R, Kandzari DE, Wang TD, Lee YH, Haro C, Pathak A Conference contribution Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension (2021) Böhm M, Tsioufis K, Kandzari DE, Kario K, Weber MA, Schmieder R, Townsend RR, et al. Journal article Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension (2021) Mahfoud F, Sievert H, Bertog S, Lauder L, Ewen S, Lengele JP, Wojakowski W, et al. Journal article Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications (2021) Mahfoud F, Weber M, Schmieder R, Lobo MD, Blankestijn PJ, Persu A, Fischell TA, et al. Journal article Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation (2021) Mahfoud F, Townsend RR, Kandzari DE, Kario K, Schmieder R, Tsioufis K, Pocock S, et al. Journal article Blood pressure lowering with alcohol-mediated renal denervation using the Peregrine infusion Catheter is independent of injection site location (2021) Mahfoud F, Bertog S, Lauder L, Bohm M, Schmid A, Wojakowski W, Parise H, et al. Journal article Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension (2021) Schmieder R, Kandzari DE, Wang TD, Lee YH, Lazarus G, Pathak A Journal article Confounding Factors in Renal Denervation Trials Revisiting Old and Identifying New Challenges in Trial Design of Device Therapies for Hypertension (2020) Kandzari DE, Mahfoud F, Bhatt DL, Boehm M, Weber MA, Townsend RR, Hettrick DA, et al. Journal article, Review article